telcagepant
Sign in to saveAlso known as MK 0974, MK-0974, MK0974
Telcagepant (INN; development code MK-0974) is a calcitonin gene-related peptide receptor antagonist which was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co.
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 566.206
Show 5 more facts
- chemical formula
- C₂₆H₂₇F₅N₆O₃
- canonical SMILES
- C1CC(C(=O)N(CC1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5
- isomeric SMILES
- C1C[C@H](C(=O)N(C[C@@H]1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5
- Commons category
- Telcagepant
- subject has role
- calcitonin gene-related peptide receptor antagonist
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Telcagepant (INN; development code MK-0974) is a calcitonin gene-related peptide receptor antagonist which was an investigational drug for the acute treatment and prevention of migraine, developed by Merck & Co.
In the acute treatment of migraine, it was found to have equal efficacy to rizatriptan and zolmitriptan.
Excerpted from Wikipedia’s “telcagepant” article, available under the CC BY-SA 4.0 licence.
Available in 7 languages
via Wikidata sitelinks · CC0